Breaking News

Patheon, Lonza Extend Exclusivity Period

Lonza Group and the special committee of independent directors at Patheon have extended the exclusivity period granted to Lonza, which was scheduled to expire today.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza Group and the special committee of independent directors at Patheon have extended the exclusivity period granted to Lonza, which was scheduled to expire today. The extension allows for continued discussions regarding possible strategic transactions between the two companies. The period of exclusivity will continue until terminated by either party. Other terms of the exclusivity arrangements will remain.

Because JLL Patheon Holdings LLC has announced it’s not prepared to sell its shares of Patheon at this time, discussions between Lonza and the committee include potential transactions that do not require the sale of JLL’s shares.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters